Home » Products » Pharmaceuticals » Pharmaceutical Intermediates » Benzoic acid, 4-[5-(trifluoromethyl)-1H-imidazol-2-yl]-, methyl ester
Purity : 99%
SMILES: C(OC)(=O)C1=CC=C(C2NC(C(F)(F)F)=CN=2)C=C1
| Product Name | Benzoic acid, 4-[5-(trifluoromethyl)-1H-imidazol-2-yl]-, methyl ester |
| Synonyms | Benzoic acid, 4-[5-(trifluoromethyl)-1H-imidazol-2-yl]-, methyl ester;methyl 4-(5-(trifluoromethyl)-1H-imidazol-2-yl)benzoate |
| CAS NO | 2106447-92-9 |
| Purity | 99% |
| MF | C12H9F3N2O2 |
| MW | 270.21 |
| Contact | selina@coreychem.com |
Benzoic acid, 4-[5-(trifluoromethyl)-1H-imidazol-2-yl]-, methyl ester (CAS: 2106447-92-9) is an aromatic carboxylic acid methyl ester containing a trifluoromethyl-substituted imidazole ring, commonly used as a pharmaceutical intermediate or synthetic building block.
Key characteristics:
The imidazole ring is a privileged structure in drug discovery, often found in anti-inflammatory, antimicrobial, and anticancer agents.
The trifluoromethyl (CF₃) group enhances lipophilicity, metabolic stability, and bioavailability.
The methyl ester of benzoic acid allows for further chemical transformations.
Main applications:
As an intermediate in the synthesis of bioactive molecules, particularly drugs targeting inflammation, infections, or neurological disorders.
Useful in the development of novel drug candidates.
Functions as a starting material for functionalization reactions in organic chemistry.
25KG/50KG/200KG per barrel;
Or package according to customer needs